AbbVie vs UnitedHealth Group Incorporated at a glance
Both companies operate in the Health Care sector, so these figures are broadly like-for-like.
| Metric | ABBV | UNH |
|---|---|---|
| Market cap | $457.23B | $357.95B |
| Price | $258.15 | $395.05 |
| P/E ratio (TTM) | 95.29 | 24.76 |
| P/B ratio (MRQ) | 0 | 3.17 |
| P/S ratio (TTM) | 6.58 | 0.67 |
| Revenue growth (1Y) | 8.57% | 11.81% |
| Return on equity (TTM) | -129.24% | 12.81% |
| Return on invested capital (TTM) | 21.13% | 9.58% |
| Gross margin (TTM) | 73.70% | 22.49% |
| Net margin (TTM) | 5.79% | 3.14% |
| Dividend yield (TTM) | 2.68% | 2.35% |
How they differ
AbbVie is the larger company at $457.23B versus $357.95B — about 1.3x the size.
On trailing earnings, UnitedHealth Group Incorporated is the cheaper of the two at 24.76 against 95.29 for AbbVie.
On sales, UnitedHealth Group Incorporated is the cheaper of the two at 0.67 against 6.58 for AbbVie.
UnitedHealth Group Incorporated leads on revenue growth over the past year, 11.81% against 8.57%.
AbbVie leads on return on invested capital, 21.13% against 9.58%.
AbbVie leads on gross margin, 73.70% against 22.49%.
AbbVie offers the higher yield at 2.68% against 2.35%.
Go deeper
Ratios describe the past. Whether either is worth owning depends on what you pay today.
Related comparisons
Other matchups involving AbbVie or UnitedHealth Group Incorporated.